We are live on
!
Find out more
CP
Clayton Partners Portfolio holdings
AUM
$138M
1-Year Est. Return
38.58%
This Fund
S&P 500
This Quarter
Est. Return
+6.32%
1 Year Est. Return
+38.58%
3 Year Est. Return
+98.99%
5 Year Est. Return
+121.13%
10 Year Est. Return
–
AUM
$115M
AUM Growth
+$10.2M
(+9.8%)
Cap. Flow
+$5.49M
Cap. Flow
% of AUM
4.78%
Top 10 Holdings %
Top 10 Hldgs %
52.65%
Holding
42
New
6
Increased
20
Reduced
10
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
National Health Investors
NHI
|
+$5.07M |
| 2 |
Flex
FLEX
|
+$1.57M |
| 3 |
LMACU
Liberty Media Acquisition Corporation Unit
LMACU
|
+$1.38M |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$1.37M |
| 5 |
DHI Group
DHX
|
+$847K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRT
Startek Inc.
SRT
|
+$3.47M |
| 2 |
SFE
Safeguard Scientifics, Inc.
SFE
|
+$1.56M |
| 3 |
Simplify Interest Rate Hedge ETF
PFIX
|
+$961K |
| 4 |
CF Industries
CF
|
+$823K |
| 5 |
ECHO
EchoStar
ECHO
|
+$638K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.46% |
| 2 | Technology | 15.74% |
| 3 | Healthcare | 10.27% |
| 4 | Energy | 9.32% |
| 5 | Utilities | 8.45% |
Similar funds
OCM
RF
FDC
GWM
ASM
CW
LIA
ACA
Clayton Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Clayton Partners held 42 positions worth $115M, up 9.8% from $105M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Clayton Partners deployed $5.49M of net new capital in Q4 2021, opening 6 new positions and adding to 20 existing holdings. Its largest new stake was National Health Investors: 91,641 shares worth $5.27M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Safeguard Scientifics, Inc., an estimated $1.56M trimmed.
- Clayton Partners's largest Q4 2021 buy was National Health Investors: 91,641 shares worth $5.27M.
- Clayton Partners added most to Flex in Q4 2021, an estimated $1.57M increase.
- Clayton Partners's biggest Q4 2021 reduction was Safeguard Scientifics, Inc., cutting an estimated $1.56M.
- Clayton Partners fully exited Startek Inc. in Q4 2021, selling an estimated $3.47M.
- Clayton Partners's ten largest holdings make up 53% of its $115M portfolio in Q4 2021.
- Clayton Partners opened 6 new positions and closed 4 in Q4 2021.
- Clayton Partners's portfolio value rose 9.8% quarter-over-quarter to $115M.
Based on Clayton Partners's 13F filing for Q4 2021, filed 7 Feb 2022.